|
RDH11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.06099999955356E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.9941999999682E-06 |
| Normal-vs-Stage2 |
9.037000E-01 |
| Normal-vs-Stage3 |
6.49510001338172E-10 |
| Normal-vs-Stage4 |
8.50269965546602E-10 |
| Stage1-vs-Stage2 |
7.563200E-04 |
| Stage1-vs-Stage3 |
7.841900E-03 |
| Stage1-vs-Stage4 |
1.443870E-03 |
| Stage2-vs-Stage3 |
1.71358999999649E-05 |
| Stage2-vs-Stage4 |
2.06810000002999E-06 |
| Stage3-vs-Stage4 |
4.659000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.36060001838013E-09 |
| Normal-vs-AfricanAmerican |
4.524400E-02 |
| Normal-vs-Asian |
2.77199999954014E-07 |
| Caucasian-vs-AfricanAmerican |
4.535600E-01 |
| Caucasian-vs-Asian |
5.959800E-01 |
| AfricanAmerican-vs-Asian |
3.966200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.30110000000372E-05 |
| Normal-vs-Female |
2.5782000001584E-07 |
| Male-vs-Female |
7.521400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.9913000000038E-06 |
| Normal-vs-Age(41-60Yrs) |
1.81720000047569E-07 |
| Normal-vs-Age(61-80Yrs) |
8.596500E-04 |
| Normal-vs-Age(81-100Yrs) |
1.119830E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.504000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.482000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.925400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.153200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.459800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.527600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.33020278020513E-11 |
| Classical-VS-Follicular |
5.38880051692558E-10 |
| Classical-VS-Other |
7.765000E-01 |
| Classical-VS-Normal |
3.08420000649789E-09 |
| Tall-VS-Follicular |
1.62436730732907E-12 |
| Tall-VS-Other |
2.528200E-02 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
6.803600E-02 |
| Follicular-VS-Normal |
3.416600E-01 |
| Other-VS-Normal |
2.720000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.240300E-03 |
| Normal-vs-N1 |
1.29489974298735E-10 |
| N0-vs-N1 |
1.43860000001439E-06 |
|
|
